MELBOURNE, Australia and SAN FRANCISCO, July 30, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
Rewardle Holdings Ltd ( ($AU:RXH) ) has issued an announcement. Rewardle Holdings Limited has released its ASX Appendix 4E Preliminary Final ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback